Physician profile
Scott D Lick
NPI 1356440341
$2,050.14
in general payments reported to CMS, 2019-2025
10 companies · $421 in 2025
The $421 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2020: $166 · 2021: $280 · 2022: $20.02 · 2023: $174 · 2024: $887 · 2025: $421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $807 · Consulting Fee: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $807.46 |
| Consulting Fee | $675.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,336.95 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Atricure, INC. | $181.00 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Medtronic, INC. | $162.65 | 2024 | Corevalve Evolut R |
| Bolton Medical INC | $117.77 | 2025 | Gelweave, Thoraflex Hybrid |
| Medinc of Texas | $81.05 | 2025 | |
| Edwards Lifesciences Corporation | $80.49 | 2019 | |
| La Jolla Pharmaceutical Company | $35.99 | 2024 | Giapreza |
| Lexington Medical, INC. | $29.43 | 2025 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Kerecis Limited | $12.62 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| On Target Laboratories, INC | $12.19 | 2025 | Cytalux |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Lick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.